Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Other Income / Expenses history
Currency unavailable · from the income statement
No Other Income / Expenses data reported for this period type.
Other Income / Expenses vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.63M USD | +149.5% | +268.2% | — | |
| LTM Mar 2026 | $2.85M USD | -27.9% | +11.8% | 1268.0% | |
| FY2025 | -$12K USD | — | — | 0.1% | |
| LTM Jun 2026 | -$15.1M USD | -313.4% | — | 212.0% | |
| LTM Jun 2026 | -$189.38M USD | -219.2% | — | 266.9% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -123.6% | +140.0% | 239.4% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.